Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 246.55M | 104.20M | 96.58M | 101.25M | 165.15M |
| Total Receivables | 430.50M | 414.68M | 407.90M | 373.73M | 427.74M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 34.65M | 28.94M | 23.18M | 25.94M | 24.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.24M | 59.30M | 16.34M | 20.05M | 51.59M |
| Total Current Assets | 727.93M | 607.12M | 544.01M | 520.97M | 669.25M |
|
|
|||||
| Total Current Assets | 727.93M | 607.12M | 544.01M | 520.97M | 669.25M |
| Net Property, Plant & Equipment | 9.87M | 10.59M | 15.09M | 16.50M | 17.43M |
| Long-term Investments | 1.14B | 1.14B | 1.14B | 1.12B | 1.12B |
| Goodwill | 1.14B | 1.14B | 1.14B | 1.12B | 1.12B |
| Total Other Intangibles | 738.18M | 748.86M | 764.88M | 779.99M | 800.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.58M | 31.95M | 32.04M | 32.74M | 31.51M |
| Total Assets | 2.65B | 2.54B | 2.50B | 2.48B | 2.64B |
|
|
|||||
| Total Accounts Payable | 57.81M | 96.03M | 50.09M | 39.03M | 77.35M |
| Total Accrued Expenses | 135.45M | 100.08M | 152.07M | 116.09M | 194.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 206.98M | 198.18M | 6.22M | 6.13M | 12.70M |
| Total Finance Division Other Current Liabilities | 338.86M | 321.21M | 315.31M | 322.12M | 374.78M |
| Total Other Current Liabilities | 338.86M | 321.21M | 315.31M | 322.12M | 374.78M |
| Total Current Liabilities | 739.10M | 715.50M | 523.68M | 483.37M | 659.02M |
|
|
|||||
| Total Current Liabilities | 739.10M | 715.50M | 523.68M | 483.37M | 659.02M |
| Long-Term Debt | 647.53M | 490.52M | 599.67M | 598.78M | 597.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.59M | 24.97M | 29.32M | 30.79M | 32.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 122.49M | 121.99M | 123.24M | 124.10M | 125.05M |
| Total Liabilities | 1.52B | 1.35B | 1.28B | 1.24B | 1.41B |
|
|
|||||
| Common Stock & APIC | 1.80B | 1.80B | 1.82B | 1.81B | 1.81B |
| Retained Earnings | -845.44M | -780.82M | -758.02M | -734.88M | -736.47M |
| Treasury Stock & Other | -22.85M | -22.88M | -22.49M | -22.48M | -22.43M |
| Total Common Equity | 935.52M | 1.00B | 1.04B | 1.05B | 1.05B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 193.23M | 190.17M | 187.17M | 184.21M | 181.29M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 193.23M | 190.17M | 187.17M | 184.21M | 181.29M |
|
|
|||||
| Total Common Equity | 935.52M | 1.00B | 1.04B | 1.05B | 1.05B |
| Total Preferred Equity | 193.23M | 190.17M | 187.17M | 184.21M | 181.29M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.13B | 1.19B | 1.23B | 1.24B | 1.23B |
|
|
|||||